Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas

International Journal of Cancer

Volumn 84, Issue 5, 1999, Pages 538-543

  Salvesen, Helga B ^a   Akslen, Lars A ^a  

^a Department of Pathology   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; KI 67 ANTIGEN; LYMPHOKINE; PROTEIN P53; THROMBOSPONDIN 1; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; CELL COUNT; CHEMISTRY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; VASCULARIZATION;

CELL COUNT; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOKINES; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; THROMBOSPONDIN 1; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033595619     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19991022)84:5<538::aid-ijc17>3.0.co;2-b     Document Type: Article

References (21)

1. BARLEON, B., SOZZANI, S., ZHOU, D., WEICH, H.A., MANTOVANI, A. and MARME, D., Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 87, 3336-3343 (1996).
2. BERTIN, N., CLEZARDIN, P., KUBIAK, R. and FRAPPART, L., Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res., 57, 396-399 (1997).
3. CAMPBELL S.C., VOLPERT O.V., IVANOVICH M. and BOUCK N.P., Molecular mediators of angiogenesis in bladder cancer. Cancer Res., 58, 1298-1304 (1998).
4. DAMERON, K.M., VOLPERT, O.V., TAINSKY M.A. and BOUCK, N., Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1582-1584(1994).
5. FONTANIXI, G., VlGNATI, S., BOLDRINI, L., CHINE, S., SlLVESTRI, V., LUCCHI, M., Mussi, A., ANGELETTI, C.A. and BEVILACQUA, G., Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin. Cancer Res., 3, 861-865 (1997).
6. GROSSFELD, G.D., GINSBERG, D.A., STEIN, J.P., BOCIINER, B.H., ESRIG, D., GROSHEN, S., DUNN, M., NICHOLS, P.W., TAYLOR, C.R., SKINNER, D.G. and COTE, R.J., Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J. not. Cancer lust., 89, 219-227 (1997).
7. GUIDI, A.J., ABU-JAWDEH, G., TOGNAZZI, K., DVORAK, H.F. and BROWN, L.F., Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer, 78, 454-460(1996).
8. Guo, N., ZABRENETZKY, VS., CHANDRASEKARAN, L., SIPES, J.M., LAWLER, J., KRUTZSCH, H.C. and ROBERTS, D.D., Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin 1. Cancer Res., 58, 3154-3162(1998).
9. HANAHAN, D. and FOLKMAN, J., Patterns and emerging mechanisms of the angiogenetic switch during tumorigenesis. Cell, 86, 353-364 (1996).
10. IRUELA-ARISPE, M.L., PORTER, P., BORNSTEIN, P. and SAGE, E.H., Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J. din. Invest., 97, 403-412 (1996).
11. JOSEPH, I.E. and ISAACS, J.T., Macrophage role in the anti-prostate cancer response to one class of antianaiogenic aaents. J. Nat. Cancer Inst., 90, 1648-1653(1998).
12. LEE, A.H., DUBLIN, E.A., BOBROW, L.G. and POULSOM, R., Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J. Pathol, 185, 394-401(1998).
13. LEEK, R.D., LEWIS, C.E., WHITEIIOUSE, R., GREENALL, M., CLARKE, J. and HARRIS, A.L., Association of macrophage infiltration with angiogenesis and proanosis in invasive breast carcinoma. Cancer Res., 56, 4625-4629 (1996).
14. SALVESEN, H.B., IVERSEN, O.E. and AKSLEN, L.A., Independent prognostic importance of microvessel density in endometrial carcinoma. Brit. J. Cancer, 77, 1140-1144 (1998a).
15. SALVESEN, H.B., IVERSEN, O.E. and AKSLEN, L.A., Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. Clin. Cancer Res., 4, 2779-2785 (1998&).
16. SALVESEN, H.B., IVERSEN, O.E. and AKSLEN, L.A., Prognostic significance of anciogenesis, Ki-67, p53 and p21 expression-a population-based endometrial carcinoma study. J. din. Oncol, 17, 1382-1390(1999).
17. TOKUNAGA, T., NAKAMURA, M., OSHIKA, Y., ABE, Y., OZEKI, Y., FUKUSHIMA Y, HATANAKA, H., SADAHIRO, S., KUIMA, H., TSUCHIDA, T., YAMAZAKI, H., TAMAOKI, N. and UEYAMA, Y, Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Brit. J. Cancer, 79, 354-359 (1999).
18. WEIDNER, N., SEMPLE, J.P., WELCH, W.R. and FOLKMAN, J., Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Éngl. J. Med., 324, 1-8(1991).
19. YAMASHITA, Y, SENDO, S., HOSOKAWA, T., TUSZYNSKI, G., KUROIIIJI T., BEPPU, R., SHINOHARA, T., KINUGASA T. and SHIRAKUSA, T., Exogenous thrombospondin stimulates the proliferation of non-thrombospondinproducing cells. Int. J. Oncol., 13, 355-359 (1998).
20. ZACHARY, I., Vascular endothelial growth factor. Int. J. Biochem. Cell Biol., 30, 1169-1174(1998).
21. ZIIANG, L., SCOTT, P.A., TURLEY, H., LEEK, R., LEWIS, C.E., GATTER, K.C., HARRIS A.L., MACKENZIE, I.Z., REES, M.C. and BICKNELL, R., Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J. Pathol., 185, 402-408 (1998).